Select a Region North America


Calvin Fujimoto



Commercialization, Data & Analytics, Digital Medicine, Market Access, Market Research

Calvin is a Consultant at EVERSANA MANAGEMENT CONSULTING, possessing industry experience across several therapeutic areas, with an emphasis in forecasting, data analytics and digital therapeutics.

Prior to joining EVERSANA, Calvin was a Consultant with IQVIA’s Commercial Effectiveness Services team in Canada. With this team, he gained experience deploying trend-based forecasting models, conducting physician segmentations and KOL mapping, aligning and setting sales force quotas across Canada, and deploying big data and analytics capabilities across project types.

During his MBA, Calvin completed three internships in the healthcare space; Business Analyst at Sanofi Genzyme, Corporate Planning at Kensington Health and Marketing Associate at Stryker.

Calvin holds an MBA from McMaster University and BScH in Life Sciences from Queen’s University.

Articles by Calvin Fujimoto

Harnessing the Commercial Promise of Prescription Drug Use-Related Software (PDURS)

The FDA’s draft guidance on Prescription Drug Use-Related Software (PDURS) offers pharmaceutical manufacturers a novel strategy to enhance a drug’s label by enabling an HCP to prescribe software alongside the drug at the HCP’s discretion. The new framework makes it easier than before to pair software with a medication to help patients manage complex dosing, […]

Interested in scheduling a meeting or speaking event?

Contact Us